DJIA 17,067.56 -30.89 -0.18%
NASDAQ 4,598.19 17.92 0.39%
S&P 500 2,002.28 -1.09 -0.05%
market minute promo

120.10 2.80 (2.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $120.10 2.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $117.28
Previous Close $117.30
Daily Range $116.67 - $120.43
52-Week Range $98.04 - $153.10
Market Cap $40.3B
P/E Ratio -49.91
Dividend (Yield) $0.00 (0.0%)
Volume 1,916,662
Average Daily Volume 2,897,392
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

Today's Top Performers In Drugs

Valeant Pharmaceuticals Part XII: the rolling solvency calculation

Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclai

Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims

Allergan Seeks Court Order to Stop Valeant, Affiliates - Analyst Blog

Allergan Seeks Court Order to Stop Valeant, Affiliates - Analyst Blog

Hedge Fund Manager Bill Ackman with a Very Profitable Year

Stock Market Today: Stocks Up Slightly but S&P Above 2,000 Is Put to the Test

Stock Market Today: Equities Poised to Extend Record Gains

How Valeant Continues To Hide Important Financial Data From Investors That Other Pharmas Disclose

TEVA, VRX And AGN, Pushing Drugs Industry Downward

See More VRX News...

VRX's Top Competitors

VRX $120.10 (2.39%)
Current stock: VRX
JNJ $103.36 (-0.36%)
Current stock: JNJ
PFE $29.26 (-0.44%)
Current stock: PFE
RHHBY $36.56 (0.14%)
Current stock: RHHBY